Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.3. Competitive Insights
Chapter 3. U.S. Vascular Access Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of cardiovascular diseases
3.2.1.2. Increasing need for vascular access devices in oncology
3.2.1.3. Technological advancements in vascular access devices
3.2.1.4. Rising use of vascular access devices among pediatric patients
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations and product recalls
3.2.2.2. Risks associated with catheter usage
3.3. U.S. Vascular Access Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Pipeline Analysis
Chapter 4. U.S. Vascular Access Devices Market: Product Estimates & Trend Analysis
4.1. Global U.S. Vascular Access Devices Market: Product Dashboard
4.2. Global U.S. Vascular Access Devices Market: Product Movement Analysis
4.3. Global U.S. Vascular Access Devices Market by Product, Revenue
4.4. Central Venous Catheters (CVC)
4.4.1. Central Venous Catheters (CVC) market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Tunneled CVC
4.4.2.1. Tunneled CVC market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Non-Tunneled CVC
4.4.3.1. Tunneled CV market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. Peripheral Parenteral Nutrition (PPN)
4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2. Power Injected
4.5.2.1. Power Injected market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.3. Standard
4.5.3.1. Standard market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Manufacturers
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company market share analysis, 2024
5.4. Company Profiles
5.4.1. BD
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Teleflex
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. B Braun
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Medical Components, Inc
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Vygon SA
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Medtronic/Mozarc Medical
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Merit Medical/AngioDynamics
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Others
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 U.S. vascular access devices market, by product, 2018 - 2030 (USD Billion)
Table 3 Participant’s overview
Table 4 Financial performance
Table 5 Key companies undergoing expansions
Table 6 Key companies undergoing acquisitions
Table 7 Key companies undergoing collaborations
Table 8 Key companies launching new products
Table 9 Key companies undergoing partnerships
Table 10 Key companies undertaking other strategies
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 U.S. vascular access devices market: market outlook
Fig. 8 U.S. vascular access devices competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 U.S. vascular access devices market driver impact
Fig. 13 U.S. vascular access devices market restraint impact
Fig. 14 U.S. vascular access devices: Product movement analysis
Fig. 15 U.S. vascular access devices: Product outlook and key takeaways
Fig. 16 Central Venous Catheters (CVC) market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 17 Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 18 Non-Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 Peripherally Inserted Central Catheter (PICCs) market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Power Injected market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 Standard market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Key company categorization
Fig. 23 Strategy mapping
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
